For clinical researchers, the most valuable insights are often trapped in unstructured formats.
The daily deluge of doctor's notes, discharge summaries, and progress reports holds real-world patient data. Unlocking it requires painstaking manual de-identification and coding.
Amorphous AI, an Oxford startup, bets a multi-agent AI system called Striata can automate this. It transforms raw clinical text into analysis-ready data in real time [SNOMED International, post-2024].
The core bet: standardize messy data at ingestion for a "data team of one" [Amorphous AI, Unknown]. Striata ingests text, de-identifies for privacy, maps to SNOMED CT, LOINC, ICD-10.
Output fuels studies, real-world evidence, operational decisions on cost and efficiency [Amorphous AI, Unknown].
This places Amorphous AI in crowded healthtech. Clinical NLP and RWE has established players, funded startups.
Early validation: SNOMED International case study on Striata [SNOMED International, post-2024]. Path to adoption needs accuracy, hospital IT integration, regulatory validation.
For chronic conditions, real-world evidence from practice could improve care. Yet generation is manual, slowing discovery.
Amorphous AI aims to remove friction. Technology awaits peer-reviewed validation, clinical partnerships.
The company is formative, pre-revenue. UK/Latvia entities registered, $3.3M pre-seed reported [LinkedIn, Unknown].
Watch for first hospital deployment, validation studies on Striata.
Sources
- [SNOMED International, post-2024] SNOMED in Action: Amorphous AI | https://www.snomed.org/snomed-in-action/amorphous-ai
- [Amorphous AI, Unknown] Amorphous Technology Whitepaper | https://amorphous.health/whitepaper
- [LinkedIn, Unknown] Nikita Trojanskis - Amorphous AI | https://www.linkedin.com/in/nikita-trojanskis-078906146/
- [Companies House, 2024] AMORPHOUS AI LTD | https://find-and-update.company-information.service.gov.uk/company/16979345
- [Lursoft, Sep 2024] SIA Amorphous AI | https://company.lursoft.lv/en/amorphous-ai/40203592108